Identification of redox sensitive thiols of protein disulfide isomerase using isotope coded affinity technology and mass spectrometry

Regulation of the redox state of protein disulfide isomerase (PDI) is critical for its various catalytic functions. Here we describe a procedure utilizing isotope-coded affinity tag (ICAT) technology and mass spectrometry that quantitates relative changes in the dynamic thiol and disulfide states of human PDI. Human PDI contains six cysteine residues, four present in two active sites within the a and a' domains, and two present in the b' domain. ICAT labeling of human PDI indicates a difference between the redox state of the two active sites. Furthermore, under auto-oxidation conditions an approximately 80% decrease in available thiols within the a domain was detected. Surprisingly, the redox state of one of the two cysteines, Cys-295, within the b' domain was altered between the fully reduced and the auto-oxidized state of PDI while the other b' domain cysteine remained fully reduced. An interesting mono- and dioxidation modification of an invariable tryptophan residue, Trp-35, within the active site was also mapped by tandem mass spectrometry. Our findings indicate that ICAT methodology in conjunction with mass spectrometry represents a powerful tool to monitor changes in the redox state of individual cysteine residues within PDI under various conditions.     

Triazenide complexes of the heavier alkaline earths: synthesis, characterization, and suitability for hydroamination catalysis

A series of triazenide complexes of the heavier alkaline earths, Ca, Sr and Ba, have been synthesized by either protonolysis or salt metathesis routes. Although complexes of the form [{Ar 2N 3}M{N(SiMe 3) 2}(THF) n ] (M = Ca, n = 2; M = Sr, n = 3; Ar = 2,6-diisopropylphenyl) and [{Ar 2N 3}Ca(I)(THF) 2] 2 could be isolated and characterized by X-ray crystallography, solution studies revealed the propensity of these species to undergo Schlenk-like redistribution with the formation of [{Ar 2N 3} 2M(THF) n ] (M = Ca, n = 1; M = Sr, n = 2). The latter compounds have been synthesized independently. In the case of the large barium dication, attempts to synthesize the heaviest analogue of the series, [{Ar 2N 3} 2Ba(THF) n ], failed and led instead to the isolation of the potassium barate complex [K{Ar 2N 3}Ba{N(SiMe 3) 2} 2(THF) 4]. Single crystal X-ray diffraction studies demonstrated that, although in all the aforementioned cases the triazenide ligand binds to the electrophilic group 2 metal centers via symmetrical kappa (2)- N, N-chelates, in the latter compound an unprecedented bridging mode is observed in which the triazenide ligand coordinates through both terminal and internal nitrogen centers. A series of density-functional theory computational experiments have been undertaken to assist in our understanding of this phenomenon. In further experiments, the calcium and strontium amide derivatives [{Ar 2N 3}M{N(SiMe 3) 2}(THF) n ] (M = Ca, n = 2; M = Sr, n = 3) proved to be catalytically active for the intramolecular hydroamination of 1-amino-2,2-diphenylpent-4-ene to form 2-methyl-4,4-diphenylpyrrolidine, with the calcium species demonstrating a higher turnover number than the strontium analogue ( 2a, TOF = 500 h (-1); 2b, TOF = 75 h (-1)). In these instances, because of ambiguities in the structural charcterization of the precatalyst in solution, such quantification holds little value and detailed catalytic studies have not been conducted.     

Ring-closing metathesis: novel routes to aromatic heterocycles

Olefin metathesis has been established as an important and general reaction in synthetic organic chemistry. Recently, it has attracted interest as a powerful tool for the construction of aromatic heterocycles. The importance of heteroaromatic motifs in medicinal chemistry and biology, as well as the efficiency and wealth of metathesis transformations, have resulted in significant success in this rapidly developing area.     

Pilot Quality-Assurance Study of a Third-Generation Batch-Mode Clinical-Scale Automated Xenon-129 Hyperpolarizer

We present a pilot quality assurance (QA) study of a clinical-scale, automated, third-generation (GEN-3) ¹²⁹Xe hyperpolarizer employing batch-mode spin-exchange optical pumping (SEOP) with high-Xe densities (50% natural abundance Xe and 50% N₂ in ~2.6 atm total pressure sourced from Nova Gas Technologies) and rapid temperature ramping enabled by an aluminum heating jacket surrounding the 0.5 L SEOP cell. ¹²⁹Xe hyperpolarization was performed over the course of 700 gas loading cycles of the SEOP cell, simulating long-term hyperpolarized contrast agent production in a clinical lung imaging setting. High levels of ¹²⁹Xe polarization (avg. %P_Xe = 51.0% with standard deviation σ_PXe = 3.0%) were recorded with fast ¹²⁹Xe polarization build-up time constants (avg. T_b = 25.1 min with standard deviation σ_Tb = 3.1 min) across the first 500 SEOP cell refills, using moderate temperatures of 75 °C. These results demonstrate a more than 2-fold increase in build-up rate relative to previously demonstrated results in a comparable QA study on a second-generation (GEN-2) ¹²⁹Xe hyperpolarizer device, with only a minor reduction in maximum achievable %P_Xe and with greater consistency over a larger number of SEOP cell refill processes at a similar polarization lifetime duration (avg. T₁ = 82.4 min, standard deviation σ_T1 = 10.8 min). Additionally, the effects of varying SEOP jacket temperatures, distribution of Rb metal, and preparation and operation of the fluid path are quantified in the context of device installation, performance optimization and maintenance to consistently produce high ¹²⁹Xe polarization values, build-up rates (T_b as low as 6 min) and lifetimes over the course of a typical high-throughput ¹²⁹Xe polarization SEOP cell life cycle. The results presented further demonstrate the significant potential for hyperpolarized ¹²⁹Xe contrast agent in imaging and bio-sensing applications on a clinical scale.     

Syntheses of arsinolipids: non‐isosteric analogues of phospholipids

Reaction of alkaline benzenearsonous and 2,3‐dihydroxypropylarsonous acids with rac‐glycidol affords the corresponding arsinic acids, which after reduction with thiophenol are acylated with either fatty‐acid chlorides/pyridine or fatty acids/dicyclohexylcarbodiimide/4‐dimethylaminopyridine and oxidized with hydrogen peroxide to give the arsinolipids (rac‐2,3‐diacyloxypropyl)phenylarsinic and bis‐(rac‐2,3‐diacyloxypropyl)arsinic acids. The latter is a non‐isosteric analogue of bisphosphatidic acid. Copyright © 2000 John Wiley & Sons, Ltd.     

On the direct reduction of arsonic acids to arsenoso compounds: mechanisms and preparations†

By using a variety of reducing agents, either alone or in the presence of iodide as a catalyst, the reduction of arsonic acids to arsenoso compounds and/or arsonous acids has been studied. The solvent and temperature are important for a clean reduction. The mechanism of the reduction involves prior protonation of the  AsO₃H₂ group, and can be rationalized in the framework of the ‘hard and soft acids and bases’ principle, which is used to predict other reducing systems and to explain other literature data. For preparative purposes, triphenylphosphine/iodine, hexamethylphosphorous triamide/iodine and ascorbic acid/iodine give flexibility of choice depending on the substrate. The first two of these systems decompose arsonic acids with a weak C–As bond but the last system is sufficiently mild towards the same arsonic acids. Copyright © 2000 John Wiley & Sons, Ltd.     

Synthesis of C-19-functionalized 1alpha-hydroxyvitamin D(2) analogues via ring-closing metathesis

A heteroatom-tethered regioselective ring-closing metathesis reaction was used for the C-19 functionalization of 1alpha-hydroxy-5,6-trans-vitamin D(2) analogues. Applications of the reaction to form a range of analogues by manipulation of the tether using both organolithium reagents and Diels-Alder cycloadditions are described.     

A quantum mechanical explanation of the structure of vinyl cation based on a CASSCF/CASMP2 study

An ab-initio CASSCF/CASMP2 study on the structures and energies of the classical and bridged forms of the vinyl cation is presented. Our calculations which are in agreement with the experimental results predict that the bridged form of the vinyl cation (C₂H₃ ⁺) is more stable than its classical counterpart and is the unique species on the potential energy surface. A quantum mechanical explanation based in the notion of electron correlation energy and in Boltzmann distribution shows that the classical form is considered to be a transient species having a fleeting existence.     

Ultrafast phosphazene‐promoted controlled anionic polymerization of styrenic monomers

The anionic polymerization of styrenic monomers with phosphazene bases as promoters, utilizing “seeding” technique in a nonpolar solvent and at room temperature was studied. In all experiments, the phosphazene base (t‐BuP₄, t‐BuP₂, and t‐BuP₁) was added in an equimolar amount to the organolithium initiator after the formation of oligomers (2 min) by conventional anionic polymerization. When t‐BuP₄ was used, the polymerization of styrene and 4‐methylstyrene was extremely fast (100 % conversion within 5 min) and the final homopolymers exhibited narrow molecular weight distribution and controlled molecular characteristics. Likewise, when weaker bases were employed, the polymerization was also controlled but showing slower reaction rate. To examine the “livingness” of this system, block copolymers were synthesized by sequential monomer addition. Further studies were conducted in order to extend this novel method to the anionic polymerization of dienes. © 2018 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2019 , 57, 456–464     

NMR Hyperpolarization Techniques for Biomedicine

Recent developments in NMR hyperpolarization have enabled a wide array of new in vivo molecular imaging modalities, ranging from functional imaging of the lungs to metabolic imaging of cancer. This Concept article explores selected advances in methods for the preparation and use of hyperpolarized contrast agents, many of which are already at or near the phase of their clinical validation in patients.